EODData

MEMBERSHIP REGISTER LOG IN

AMEX, CANF: Can-Fite Biopharma Ltd ADR

29 Oct 25 17:05
LAST:

0.4390

CHANGE:
 0.02		OPEN:
0.4610		HIGH:
0.4689		ASK:
1.9500		VOLUME:
202.1K
CHG(%):
4.77		PREV:
0.4610		LOW:
0.4335		BID:
1.7200		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Oct 250.46100.46890.43350.4390202.1K
28 Oct 250.47000.48140.46050.461057.7K
27 Oct 250.49000.49000.47000.4749150.4K
24 Oct 250.48000.48140.46000.4613259.2K
23 Oct 250.49910.50200.48000.4827125.6K
22 Oct 250.50000.50990.49100.499184.7K
21 Oct 250.51600.51600.50000.505180.1K
20 Oct 250.51000.53280.50200.5162121.6K
17 Oct 250.54250.54950.49100.5010336.4K
16 Oct 250.53000.55120.53000.5400436.9K

COMPANY PROFILE

Name:Can-Fite Biopharma Ltd ADR
About:Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. The company was incorporated in 1994 and is headquartered in Ramat Gan, Israel.
Sector:Healthcare
Industry:Biotechnology
Address:26 Ben Gurion Street, Ramat Gan, Israel, 5257346
Website:https://www.canfite.com
CUSIP:13471N201
CIK:0001536196
ISIN:US13471N2018
FIGI:BBG003CMFDM2
LEI:549300ZLRH6GSBOHFZ59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.465.6%
MA10:0.4911.2%
MA20:0.5320.1%
MA50:0.6036.3%
MA100:0.7673.0%
MA200:1.07143.8%
RSI14:27.43 
WPR14:-100.00 
MTM14:-0.09
ROC14:-0.17 
ATR:0.03 
Week High:0.5116.2%
Week Low:0.431.3%
Month High:0.6445.8%
Month Low:0.43143.8%
Year High:2.50469.5%
Year Low:0.431.3%
Volatility:3.07 

RECENT SPLITS

Date Ratio
09 Jan 20231-10
10 May 20191-15